Methicillin-resistant Staphylococcus aureus (MRSA) is one of the pathogens driving interest in antimicrobial peptides as a fresh antibiotic class. AMPs tend to kill bacteria by disrupting membranes and hitting several targets at once, mechanisms that resistant strains have a hard time evading.
Recent work on this site has leaned on computational design. The CAMPER AI framework produced a peptide that kills MRSA persister cells, and a follow-up generated WP-CAMPER1, a 12-mer that killed MRSA at 4 µg/mL. A July 2026 Nature Communications study took a different route, describing a linear peptide of four D-tryptophan/D-arginine/D-lysine repeats that killed MRSA and Klebsiella pneumoniae in pneumonia models, resisted degradation, and helped restore sensitivity to existing antibiotics.
Stories here follow MRSA-active peptides, their design methods, and the broader push to answer antibiotic resistance with peptide chemistry. See #antimicrobial-peptides and #antibiotic-resistance.
A study in Nature Communications describes a linear antimicrobial peptide built from four D-tryptophan/D-arginine/D-lysine repeats that stays stable in the body and kills multidrug-resistant bacteria, including MRSA and Klebsiella pneumoniae. In bacterial pneumonia models, the peptide acted through membrane targeting alongside DNA binding, reactive-oxygen accumulation, and ATP depletion, showed low potential to drive resistance, and helped restore sensitivity to existing antibiotics.
Fadi Shehadeh, Biswajit Mishra and collaborators published CAMPER (Constraint-driven AMP Engineering with Ranking) in Nature Communications 2026, integrating machine learning with mechanistic biological features to design peptides that target MRSA persister cells. The lead candidate, WP-CAMPER1, kills S. aureus MW2 at a minimal inhibitory concentration of 4 µg/mL. A 2% topical formulation reduced bacterial burden 2.5 log10 in a murine prophylactic skin infection model; the D-enantiomer WP-CAMPER1-d achieved 1.37 log10 reduction in established biofilm infections.
A Nature Communications paper introduces CAMPER (Constraint-driven AMP Engineering with Ranking), a mechanistic AI framework that integrates machine learning with biophysical ranking to design membrane-targeting peptides against MRSA persisters and biofilms. The framework identified WP-CAMPER1, a 12-mer peptide that kills S. aureus MW2 at an MIC of 4 µg/mL; a 2% topical formulation reduced S. aureus burden by 2.5 log10 in a murine skin infection model.